Cargando…
Zebrafish-Based Screening Models for the Identification of Anti-Metastatic Drugs
Metastasis, a leading contributor to the morbidity of cancer patients, occurs through a multi-step process: invasion, intravasation, extravasation, colonization, and metastatic tumor formation. Each process is not only promoted by cancer cells themselves but is also affected by their microenvironmen...
Autores principales: | Nakayama, Joji, Makinoshima, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287578/ https://www.ncbi.nlm.nih.gov/pubmed/32455810 http://dx.doi.org/10.3390/molecules25102407 |
Ejemplares similares
-
In vivo Drug Screening to Identify Anti-metastatic Drugs in Twist1a-ER(T2) Transgenic Zebrafish
por: Nakayama, Joji, et al.
Publicado: (2023) -
A zebrafish embryo screen utilizing gastrulation identifies the HTR2C inhibitor pizotifen as a suppressor of EMT-mediated metastasis
por: Nakayama, Joji, et al.
Publicado: (2021) -
Transgenic zebrafish for modeling hepatocellular carcinoma
por: Nakayama, Joji, et al.
Publicado: (2020) -
De novo deoxyribonucleotide biosynthesis regulates cell growth and tumor progression in small-cell lung carcinoma
por: Maruyama, Ami, et al.
Publicado: (2021) -
Zebrafish Model for Screening Antiatherosclerosis Drugs
por: Han, Jichun, et al.
Publicado: (2021)